The US Food and Drug Administration’s seven-year delay in updating guidance on social media promotion of prescription drugs has garnered the attention of two Senators, who want new guidance by the end of December.
In a 14 February letter to FDA Commissioner Robert Califf, Senate Judiciary Committee chair Richard Durbin, D-IL, and Sen....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?